Paxlovid and remdesivir, which goes by the brand name Veklury, are the preferred antiviral drugs for treating eligible COVID-19 patients, according to the CDC’s interim outpatient clinical considerations updated June 15.
Read the full post on Becker's Hospital Review - Healthcare News
